Marshall Wace
XAGE

Marshall Wace’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Marshall Wace’s Portfolio XAGE Stock Details XAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-340
Closed -$100K – 3507
2022
Q3 		$100K Buy
+340
New +$99.2K ﹤0.01% 3184

Other funds holding XAGE

PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Marshall Wace's XAGE Position: Q4 2022 in Review

Marshall Wace sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q4 2022, closing a stake of 340 shares — an estimated $100K sold.

Marshall Wace first reported a position in XAGE in Q3 2022 and held it in 1 quarter. The position peaked at $100K in Q3 2022. 38 funds tracked by Wall St. Rank hold XAGE as of Q4 2022.

  • Marshall Wace reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Marshall Wace sold 340 Longevity Health Holdings, Inc. Common Stock shares in Q4 2022, an estimated $100K.
  • Marshall Wace first reported a position in Longevity Health Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Marshall Wace's Longevity Health Holdings, Inc. Common Stock position peaked at $100K in Q3 2022.
  • 38 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.